Altman Z Score Analysis of Cyclacel Pharmaceuticals Inc - Deep Dive
Latest FY Altman Z Score
Period Ending - Dec-23
Very Poor Altman Z Score
-77.41
Period Ending - Dec-22
Very Poor Altman Z Score
-1242.14
Growth
93.77 %
Latest Altman Z Score
Period Ending - 31-May-24
Very Poor Altman Z Score
-77.13
Key Inputs in Deriving Altman Z Score
(Net Working Capital / Total Assets ) * 1.2 ( -0.072 Cr / 0.880 Cr ) * 1.2 | -0.098 |
(Retained Earning / Total Assets ) * 1.4 ( -42.83 Cr / 0.880 Cr ) * 1.4 | -68.10 |
(EBIT / Total Assets ) * 3.3 ( -2.47 Cr / 0.880 Cr ) * 3.3 | -9.26 |
(Total Revenue / Total Assets ) ( 0.0389 Cr / 0.880 Cr ) | 0.0442 |
(Market Cap / Total Liabilities ) *.6 ( 0.386 Cr / 0.820 Cr ) *.6 | 0.283 |
Altman Z Score | -77.13 |
Altman Z Score Analysis of Cyclacel Pharmaceuticals Inc
Altman Z Score Ratio with value of -12.82 was highest in Year Dec-21 in last Five Years. |
Altman Z Score Ratio with value of -1242.14 was lowest in Year Dec-22 in last Five Years. |
Latest Altman Z Score Ratio with value of -77.41 is Greater than Average Altman Z Score of -275.97 in last five years. |
Other Altman Z Score Related Info of CYCC that may interest you.
Cyclacel Pharmaceuticals Inc Overview
Code | Price | Previous Price | Price Change | Sector |
---|---|---|---|---|
CYCC | 2.64 | 2.02 | 30.69 % | Biotechnology |
Defination of Altman Z Score
Altman Z Score is a widely used metric by analysts and investors to analyze companies' financial position. It indicates that the companies' risks were increasing, and they may have been heading towards bankruptcy. It does not only indicate whether companies are moving towards bankruptcy, but it also indicates how financially stable and healthy they are. more ..Altman Z Score Related Ratios
PiotroskiFScore | DebtToEquityRatio |
Tsr Stability Index
Mild Stability |
FY - Historical Altman Z Score of Cyclacel Pharmaceuticals Inc
Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 |
---|---|---|---|---|---|---|---|
Altman Z Score | -77.41 | -1242.14 | -12.82 | -13.72 | -33.77 | -25.20 | -18.51 |
Change | 93.77 % | -9592.08 % | 6.58 % | 59.37 % | -33.97 % | -36.20 % | 29.16 % |
FY Chart of Altman Z Score of Cyclacel Pharmaceuticals Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)